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ABSTRACT 
Objectives: To determine the efficacy of endoscopic sinus surgery on olfactory function in 
Chronic Rhinosinusitis patients with Nasal Polyps (CRSwNP) and without Nasal Polyps 
(CRSsNP) and compare nasal obstruction and symptom evaluation (NOSE) scale and quality 
of life measures before and after surgery. 
Design: A prospective cohort study   
Setting: Royal National Throat and Nose and Ear Hospital, London UK. 
Participants: 113 patients with CRS; 60 CRSwNP and 53 CRSsNP  
Outcome measurements: Olfaction was measured using both the University of 
Pennsylvannia Smell Investigation Test (UPSIT, primary endpoint) and the ‘sense of smell’ 
visual analogue score (VAS). The NOSE scale, the SNOT 22 and Lund-Kennedy (LK) scores 
were also measured pre and post operatively at 6 months. 
Results: UPSIT significantly improved after surgery in the CRSwNP subgroup. Baseline 
UPSIT was significantly better in the CRSsNP subgroup, but the improvement after surgery 
failed to reach significance in this subgroup. Endoscopic sinus surgery significantly improved 
the patient’s VAS ‘sense of smell’ in the whole CRS population and in the CRSwNP 
subgroup. The NOSE, SNOT 22 and LK scores all improved significantly. Improvement 
measured by UPSIT correlated to SNOT-22, but a correlation between NOSE score and 
UPSIT was not found.  
Conclusions: Endoscopic sinus surgery significantly improved the patient’s perceived and 
measured sense of smell in the CRSwNP subgroup which is the most surgically responsive 
CRS subgroup. Additionally, improved olfaction in the CRSwNP sub group is likely to 
improve the patient’s quality of life. Endoscopic sinus surgery significantly improved the 
NOSE scale in both CRS groups at 6 months after surgery.
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INTRODUCTION 
Olfactory dysfunction affects approximately 5% of the UK population with a prevalence of 
over 25% in other published population studies.(1) As a sensory disorder it is more common 
than blindness and deafness and carries significant psychosocial consequences for the 
sufferer. (2;3) The two commonest causes for hyposmia/anosmia are  viral illnesses and 
chronic rhinosinusitis (CRS) which account for up to 80% of all cases, the remaining being 
due to trauma. (1) The prevalence of CRS in Europe is as high as 10.9 %, (4) and the 
treatment of choice for medical refractory CRS is endoscopic sinus surgery (ESS), with 
olfactory dysfunction as one of the four major indications, as defined by the European 
position paper of sinusitis and nasal polyps guidelines (EP3OS).(5) The general role of 
endoscopic sinus surgery in sinonasal disease is well documented and its function is to reduce 
nasal obstruction and improve ease of topical steroid application onto the nasal and sinus 
lining and in doing so potentially improve olfaction. The evidence supporting the efficacy of 
FESS in the treatment of CRS with or without polyps suggests it is as effective as medical 
treatment, but not better.(6) 
 Current evidence supports the positive effects of olfactory improvement following 
endoscopic sinus surgery in the treatment of CRS both in the short and long term and up to 5 
years post operatively.(7) Additional studies have also shown improved olfactory outcomes 
following endoscopic sinus surgery albeit not always significant.(8) Systemic and topical 
corticosteroid in the treatment of hyposmia in chronic rhinosinusitis with nasal polyposis 
(CRSwNP) have also demonstrated statistically significant improvement in several 
randomized controlled trials. (9) 
CRS subgroup analyses of olfactory outcomes using psychophysical measurements in 
patients with CRSwNP and CRSsNP have been limited with regards to analysis of quality of 
4 
 
life outcomes, olfactory function and other patient reported outcome measures (PROMs). A 
recent study evaluating CRS subgroups following endoscopic sinus surgery demonstrated a 
significant olfactory improvement in the CRSwNP sub group as measured by Sniffin sticks. 
This significant improvement was not demonstrated in the CRSsNP subgroup, although as a 
whole the general CRS population improved.(10) Interestingly this olfactory outcome has not 
been evaluated using the UPSIT psychophysical olfactory measurement tool.  
Up to now, the NOSE scale which is a commonly used PROM in septoplasty and 
septorhinoplasty surgery, has not been evaluated in the CRS population even though it has 
been recommended in such patients.(11;12) CRS studies have demonstrated that nasal 
blockage VAS scores following ESS improved significantly and correlated with improved 
olfactory function on Sniffin stick evaluation. (13) Quality of life measured by SNOT-22 
questionnaire (15) and endoscopic evaluation using the Lund-Kennedy scoring system (16) 
were previously evaluated in sinus surgery. The question remains whether a specific PROM 
looking at nasal blockage (NOSE) equally improves following ESS and also correlates with 
improved olfactory function. 
Bugten et al showed that patients with CRSwNP complained more of nasal blockage and a 
reduced sense of smell whereas patients with CRSsNP complain more of facial pain and 
headaches, but interestingly they did not find a significant difference in subjective symptom 
improvement, with both groups responding similarly following FESS.(14) 
Our aims were to determine the efficacy of endoscopic sinus surgery (ESS) on olfactory 
function in CRSwNP and CRSsNP sub groups and to further evaluate the nasal obstruction 
and symptom evaluation (NOSE) scale in the CRS population. 
 
MATERIALS AND METHODS 
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Full NHS Ethical and Research and Development (R&D) approval were granted for this 
study. 128 patients were recruited from a dedicated rhinology clinic at the Royal National 
Throat Nose and Ear Hospital, London, over a 2 year period. The indications for endoscopic 
sinus surgery (ESS) were in accordance to EPOS guidelines. Exclusion criteria were patients 
under the age of 16, pregnancy or patients who were unable to comprehend the assessment.  
 
Olfactory function was assessed subjectively pre- and post-operatively using visual analogue 
scores and objectively measured using the University of Pennsylvania smell investigation test 
(UPSIT), a validated psychophysical scratch and sniff test. UPSIT scores were calculated as 
the number of correct identifications, ranging from 0 to 40, with 40 representing perfect 
olfaction. The patient’s quality of life was measured using the SNOT-22 questionnaire and 
their nasal blockage symptoms were measured using the NOSE questionnaire. The patients’ 
nasal cavities were evaluated by the surgeon using the Lund-Kennedy scoring system. All 
measurements were repeated at 6 months post operatively. 
 
Wilcoxon matched paired tests evaluated the effect of surgery on olfaction (UPSIT, visual 
analogue scale). Spearman regression was used to assess the correlation between the scores. 
Results of surgery were dichotomized into two: good result if the SNOT-22 improved by 10 
or more and poor outcome in all other cases. Logistic regression was used to examine 
association between the outcome and UPSIT change after surgery. Effects of co-factors such 
as smoking, sex and nasal polyposis on baseline UPSIT scores were analysed using the U 
Mann Whitney test. Linear regression analysis was used to calculate the correlation between 
age and the baseline UPSIT score. Interaction of co-factors on the olfactory results of sinus 
surgery was evaluated using 2-ways ANOVA. Statistical tests including receiver operating 
characteristics were undertaken using Stata version 13.1 (StatCorp, Tx). Graphical 
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presentations were performed using GraphPad Prism 5.0a (GraphPad Software, San Diego, 
California, USA). 
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RESULTS 
Population 
 
Our population was consistent with the patients undergoing sinus surgery in a tertiary 
referral hospital (Table 1). Out of the 128 patients for whom inclusion in our study was 
offered, 113 agreed to enter the study. Half of the patients had chronic rhinosinusitis with 
nasal polyps. Mean Lund-Mackay score was 10.9 (severe chronic sinusitis on CT scan). 
Lund-Mackay score was higher in polyps patients (mean 14.9 ± 5.8) than in patients without 
polyps (mean 6.4 ± 5.3). Mean Lund-Mackay score severity was not correlated to the UPSIT 
baseline score. However, patients with nasal polyps had lower baseline UPSIT score than 
patients without polyps (p<0.0001). The UPSIT score was not significantly different in 
smoking or non-smoking patients in our population. Equally, in our population, age was not 
correlated to the baseline UPSIT score. The influence of chronic rhinosinusitis on olfaction 
measured by UPSIT was likely to be stronger than the effect of age and tobacco in our 
population. 
 
Outcome 
Outcomes are summarized in table 2. The UPSIT score in patients with nasal polyps 
improved significantly after endoscopic sinus surgery (Wilcoxon p = 0.0428). Improvement 
in subjective olfaction scored by visual analogue scale was also seen in our population 
(Wilcoxon p <0.0001) and this improvement was above all observed in the nasal polyps 
subgroup (Wilcoxon p = 0.0004). However, in our whole CRS population, olfactory 
improvement as measured by UPSIT was not significant after surgery. The UPSIT score did 
not change after surgery in 12.7% patients improved after surgery in 46.0% patients and 
worsened in 41.3% patients. However, subjective olfaction rated on a visual analogue scale 
improved in 72.5% patients, did not change in 13.7% patients and worsened in 13.7% 
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patients after sinus surgery. The SNOT-22 score, the endoscopic evaluation, the NOSE score 
and the visual analogue scale improved significantly after surgery in the whole population. 
The quality of life measured by SNOT-22 improved in 84.5% patients and decreased in 
15.5% patients after surgery.  
 
When reviewing the subgroups, baseline scores were seen to be worse in the polyp subgroup, 
but surgical improvement was especially marked in this subgroup. Among polyp patients, 
54.5% improved their UPSIT score, while 12.1% did not change and 33.3% worsened after 
surgery. Subjective olfaction was even better with 81.4% of polyp patients reporting an 
improvement on visual analogue scale, 14.8% patients without change and 3.7% patients with 
worsening of olfaction. Improvement of quality of life was observed in 90.9% polyps 
patients. The SNOT-22 decreased in 9.1% polyp patients. 
 
SNOT-22 change and UPSIT change after surgery were correlated. More than 30% of the 
SNOT-22 variance was related to UPSIT improvement after surgery in polyps patients (r2 = 
0.379, p<0.001, Figure 1). A correlation between the ‘sense of smell’ Visual Analogue Score 
and the UPSIT value was not demonstrated (Spearman R2 = 0.13) A correlation between the 
NOSE scale and UPSIT score (r2 = 0.01, p = 0.402) equally was not demonstrated. There 
was no relationship between NOSE change after surgery and UPSIT change after surgery (r2 
= 0.223, p = 0.0032).  
 
DISCUSSION 
Synopsis of key findings 
Endoscopic sinus surgery was associated with improved UPSIT ‘sense of smell’ in the 
CRSwNP subgroup which represents the most surgically responsive subgroup. Interestingly a 
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similar improvement was not demonstrated in the CRSsNP group. Endoscopic sinus surgery 
improved the patient’s perceived ‘sense of smell’ to a greater extent as measured by the VAS 
scale in the CRSwNP sub group but not in the CRSsNP group. UPSIT and VAS ‘sense of 
smell’ were not exactly correlated. The SNOT 22 outcome equally improved significantly in 
both subgroups following surgery and importantly a relationship between improved SNOT 22 
outcomes and improved UPSIT measurements in the CRSwNP sub group was demonstrated. 
This study was the first to evaluate the NOSE scale as an outcome measurement for nasal 
blockage in the CRS population. The NOSE scale significantly improved in both the CRSsNP 
and CRSwNP subgroups following endoscopic sinus surgery, although a direct relationship 
with improved olfaction was not demonstrated. The NOSE questionnaire provides another 
validated symptom-specific quality of life questionnaire, which specifically assesses the 
symptom of nasal obstruction and its consequences.  
On further sub-group analysis the impact of smoking, age and gender were not shown to 
affect baseline olfaction nor olfactory function following surgery, suggesting that sinus 
disease was the most important contributor to impaired olfaction in our cohort, 
overshadowing other factors. We did not have a single case of anosmia in our surgical cohort 
and although the majority of our patients were hyposmic prior to surgery and their sense of 
smell improved post operatively, they still remained hyposmic which is in keeping with 
current evidence. 
Comparison with other studies 
The findings in our study are in agreement with results from a recent study evaluating 
olfactory outcomes in the CRSwNP subgroup. A significant olfactory improvement in 
CRSwNP but not in CRSsNP was demonstrated using the Sniffin Stick identification 
test.(10)Shriever et al in 2013 looked at the effects of nasal surgery, including both sinus 
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surgery and septal surgery, on olfaction using the 16 item odor identification ‘Sniffin’ stick 
test. At 3.5 months post operatively there was a significant improvement in the sinus surgery 
arm as opposed to a non-significant improvement in the septal surgery arm and interestingly 
they both became non-significant at 12 months. They also found that polyps and eosinophilia 
were good prognostic factors for olfactory outcome improvement. Conversely, in the non-
polyp group, the improvement was not significant (15). Rowe-Jones et al performed a 5 year 
prospective study of post FESS CRS patients of whom 75% were CRSwNP and 
demonstrated a significant improvement in measured olfaction at 2 years post surgery which 
became non significant at 5 years. Rudmik and Smith performed a literature review on the 
efficacy of FESS in CRS-related olfactory dysfunction and concluded the evidence 
supporting its efficacy is equivocal and not significant.  (16). Lund et al demonstrated  a 
significant improvement in olfactory function following ESS.(17)  
 
Pade et al demonstrated an improvement in the sense of smell, as measured by Sniffin sticks 
in 23% of their post operative patients, no change was seen in 68%, and a decreased function 
was seen in 9% of the patients. In terms of the sense of smell, nasal surgery resulted in the 
highest success rates in patients with eosinophilia and a high degree of polyposis.(18) 
Dealank et al demonstrated post-endoscopic sinus surgery olfactory improvements in 70% of 
their CRS population and olfaction changed for the worse in 8%.(19) 
In our study, measured UPSIT olfactory function did not change after surgery in 12.7% 
patients, improved after surgery in 46.0% patients and worsened in 41.3% patients. 
Interestingly on subjective olfaction measurements, improvement was seen in 72.5% patients, 
did not change in 13.7% patients and worsened in 13.7% patients after sinus surgery. This 
mismatch between the UPSIT and VAS olfactory scores relates to patients with improved 
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subjective olfactory preception but worse objective olfactory function. With the use of Sniffin 
sticks, Pade and Hummel deemed an olfactory improvement of three or more points as a 
significant change and this may account for the difference in the UPSIT measurements. 
Minovi et al, when analyzing olfactory outcome predictors for nasal surgery, found the 
highest success rates were in women, patients with a high degree of polyposis, and aspirin-
intolerance. Neither age, presence of asthma, nor the number of preoperative surgical 
interventions had a significant impact on the outcome of surgery in terms of chemosensory 
function. (20) However there is increasing evidence supporting early surgical intervention, in 
medically refractory CRS, with higher post operative healthcare needs exhibited when the 
delay for surgery is longer.(21) 
 
.  
 
 Clinical applicability of the study 
Our study has highlighted that the CRSwNP subgroup represents the most surgically 
responsive subgroup of CRS patients for olfactory improvement and will enable better 
informed consent for patients. Also according to our results, better quality of life is more 
likely to occur with improved olfactory function in the CRSwNP subgroup. This would imply 
that olfactory impairment in CRS is probably more complex than just a conductive problem 
and would also explain why there is a lack of a relationship with the NOSE scale outcome. 
According to our data, up to one third of the SNOT-22 variance was related to UPSIT 
change, whereas theoretically, as olfaction is only one of the 22 questions it should be 1/22. 
This implies that impaired olfaction has a greater impact on quality of life than 
expected.Conversely, there is a significant proportion of patients whose measured and 
12 
 
perceived sense of smell becomes worse after surgery, which needs to be explained at the 
time of informed consent. However, there were no cases of post operative anosmia. 
 
Study Limitations 
One of the limitations of this study is the lack of pre-operative stratification of severity and 
duration of hyposmia, thus preventing a sub-group analysis of olfactory improvement for 
these factors. Also UPSIT evaluation is potentially not sensitive enough for complete 
olfactory detection as it only measures identification as opposed to threshold and 
discrimination and remains a subjective measure. The objective olfactory outcome 
measurements include event-related olfactory potentials which require precise odorant 
delivery via an olfactometer. Equally we did not correlate the NOSE scale outcome to an 
objective measure of nasal airflow such as Nasal Inspiratory Peak Flow (NIPF) which could 
be incorporated in future studies. 
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CONCLUSION 
 
Patients’ perceived and measured sense of smell in the CRSwNP subgroup improves 
significantly following ESS and represents the most surgically responsive CRS subgroup. 
Additionally, we have demonstrated that improved olfaction in the post surgery CRSwNP sub 
group is more likely to also improve the patient’s quality of life. The NOSE scale is a 
sensitive outcome measure in the CRS population although it does not interact with olfaction.  
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Figure 1 
 
 
 
 
 
 
Table 1 
 
Patients Data 
Demographic 
Data 
Total, No 113 
Age, mean ( sd), yr 46.3 ( 14.9) 
Sex, No (%) 48 ♀ (42.5%) 
65 ♂ (57.5%) 
Clinical Data Polyposis, No (%) 
Revision surgery, No (%) 
Smoking, No (%) 
60 (53.1%) 
13 (11.5%) 
24 (21.2%) 
CT-scan Lund-Mackay score, mean ( sd)  10.9 ( 6.9) 
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Table 2 
Outcome measures pre-operative post-operative p 
UPSIT 
(value) 
Whole population, mean ( sd) 
CRSsNP 
CRSwNP 
25.5 (9.9) 
29.5 (7.8) 
21.9 (10.4) 
26.6 (9.7) 
29.1 (8.1) 
24.3 (10.5) 
0.38 ns 
0.34 ns 
0.04 * 
NOSE score Whole population, mean ( sd) 
CRSsNP 
CRSwNP 
61.2 (30.6) 
54.2 (32.7) 
67.2 (27.7) 
27.8 (25.4) 
31.8 (27.2) 
22.7 (4.7) 
<0.01 *** 
0.01 * 
<0.01 *** 
SNOT-22 
score 
Whole population, mean ( sd) 
CRSsNP 
CRSwNP 
53.4 (24.8) 
52.8 (26.3) 
54.0 (23.7) 
28.9 (23.8) 
32.5 (25.4) 
25.8 (22.2) 
<0.01 *** 
<0.01*** 
<0.01*** 
Lund-
Kennedy 
score 
Whole population, mean ( sd) 
CRSsNP 
CRSwNP 
4.6 (2.7) 
3.2 (2.3) 
5.7 (2.6) 
2.1 (1.7) 
2.1 (1.4) 
2.1 (1.8) 
<0.01 *** 
0.15 ns 
<0.01 *** 
VAS score 
on overall 
nose sympt 
Whole population, mean ( sd) 
CRSsNP 
CRSwNP 
6.6 (2.8) 
6.3 (2.7) 
6.9 (2.8) 
3.4 (2.8) 
4.4 (2.8) 
2.4 (2.5) 
<0.01 *** 
0.04 * 
<0.01 *** 
VAS score 
on sense of 
smell 
Whole population, mean ( sd) 
CRSsNP 
CRSwNP 
6.0 (3.5) 
4.4 (3.5) 
7.4 (2.8) 
3.7 (3.4) 
2.5 (3.0) 
5.0 (3.4) 
<0.01 *** 
0.05 ns 
<0.01*** 
 
 
 
Legends 
Figure 1 
Comparison of SNOT-22 change (Y-axis) and UPSIT change after surgery (Y-axis) in 
CRSwNP. SNOT-22 change and UPSIT change after surgery were fairly correlated, and 
more than 30% of the SNOT-22 variance was related to UPSIT improvement after 
surgery. 
 
 
